Central nervous system involvement in gyrate atrophy of the choroid and retina with hyperornithinaemia
The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Abstract
In gyrate atrophy of the choroid and retina with hyperornithinaemia (GA), a genetically determined deficiency of ornithine delta-aminotransferase activity leads to high ornithine concentrations in body fluids. GA is characterized by centripetally progressing retinal and choroidal destruction and selective atrophy with tubular aggregates in type II skeletal muscle fibres. These findings have been suggested to be mediated by hyperornithinaemia-induced deficiency of high-energy creatine phosphate. As abnormal brain magnetic resonance images and electroencephalograms are found in another disorder of creatine metabolism, guanidinoacetate methyltransferase deficiency, we investigated the central nervous system involvement in GA, which seems to be associated with a milder degree of phosphocreatine deficiency. We compared 23 untreated GA patients with age-matched healthy controls, and with 9 patients who had received creatine or creatine precursor supplementation daily for several years. The mean age of the patients (32 +/- 18 years) was similar to that of the controls (36 +/- 22 years). The MRI or EEG findings of the patients on creatine supplementation did not differ from those of the untreated group. Brain MRI revealed degenerative lesions in the white matter in 50% of the GA patients, and 70% of the patients had premature atrophic changes, with a striking increase in the number of Virchow's spaces. Of the patients whose EEG was recorded, 58% had abnormal slow background activity, focal lesions or high-amplitude beta rhythm (> 50 microV). The EEG findings were not associated with the MRI changes or with the age or the sex of the patients. Early degenerative and atrophic brain changes and abnormal EEG are thus features of GA, in addition to the well-characterized eye and muscle manifestations.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Results from studies spanning up to 72 months in this patient population indicate that creatine supplementation can slow disease progression while also helping to maintain levels of type II skeletal muscle fiber content [68,69].”
From Creatine Supplementation in Children and Adolescents (2021) · cites this paper as [68]
Citations
Cites
A new mitochondrial disease associated with mitochondrial DNA heteroplasmy.
Holt, I. J., Harding, A. E., Petty, R., & MORGAN-HUGHES, J. A. (1990) · PubMed · Cited by 1,005
Creatine deficiency in the brain: A new, treatable inborn error of metabolism
Stöckler, S., Holzbach, U., Hanefeld, F., Marquardt, I., Helms, G., Requart, M., Hänicke, W., & Frahm, J. (1994) · Pediatric Research · doi:10.1203/00006450-199409000-00023 · Cited by 417
Current practice of clinical electroencephalography
Hughes, J. R. (1990) · Electroencephalography and Clinical Neurophysiology · doi:10.1016/0013-4694(90)90008-8 · Cited by 414
Cerebral structure on MRI, Part I: Localization of age-related changes
Jernigan, T. L., Archibald, S. L., Berhow, M. T., Sowell, E. R., Foster, D. S., & Hesselink, J. R. (1991) · Biological Psychiatry · doi:10.1016/0006-3223(91)90210-d · Cited by 388 · cited 1×
“Owing to the reduced cortical grey matter volume, the ventricular and sulcal sizes increase gradually before the age of 60 years, and then more rapidly ( Jernigan et al 1990, 1991 ).”
BackgroundLarge Virchow-Robin spaces: MR-clinical correlation.
(1989) · PubMed Central · Cited by 331
Mitochondrial Encephalomyopathies
DiMauro, S., & Moraes, C. T. (1993) · Archives of Neurology · doi:10.1001/archneur.1993.00540110075008 · Cited by 301
Gyldensted, C. (1977) · Neuroradiology · doi:10.1007/bf00496982 · Cited by 280 · cited 1×
“To quantify the degree of brain atrophy, several indices were acquired of the dimensions of the cerebrospinal Ñuid space, brain and skull using a method previously applied for computed tomography of the brain (Gyllensted 1977 ; Meese et al 1980).”
MethodJernigan, T. L. (1990) · Archives of Neurology · doi:10.1001/archneur.1990.00530010035015 · Cited by 257
RAISED PLASMA-ORNITHINE AND GYRATE ATROPHY OF THE CHOROID AND RETINA
Simell, O., & Takki, K. (1973) · The Lancet · doi:10.1016/s0140-6736(73)90667-3 · Cited by 251 · cited 1×
“Several mutations in the gene encoding ornithine d-aminotransferase (EC 2.6.1.13 ; OAT) abolish the enzyme activity and lead to a 10- to 20-fold increase in the plasma ornithine concentration (Simell and Takki 1973 ; Kaiser-Kupfer et al 1981 ; Takki and Milton 1981 ; Valle and Simell 1995).”
BackgroundInfluentialSelf-citationStöckler, S., Hanefeld, F., & Frahm, J. (1996) · The Lancet · doi:10.1016/s0140-6736(96)04116-5 · Cited by 240
Research works printed but not linked: 1
- Valle D, 1995, The Metalobic and Molecular Bases of Inherited Disease, 1147
Cited by
Kreider, R. B., Kalman, D. S., Antonio, J., Ziegenfuss, T. N., Wildman, R., Collins, R., Candow, D. G., Kleiner, S. M., Almada, A. L., & Lopez, H. L. (2017) · Journal of the International Society of Sports Nutrition · doi:10.1186/s12970-017-0173-z · Cited by 1,057
Creatine in health and disease
Kreider, R. B., & Stout, J. R. (2021) · Nutrients · doi:10.3390/nu13020447 · Cited by 227
Wyss, M., & Schulze, A. (2002) · Neuroscience · doi:10.1016/s0306-4522(02)00088-x · Cited by 175
Synthesis and transport of creatine in the CNS: Importance for cerebral functions
Béard, E., & Braissant, O. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06935.x · Cited by 192
“While GA patients may develop with normal intelligence, electroencephalography and magnetic resonance imaging analysis have, however, demonstrated unspecific abnormalities and premature degenerative changes in CNS (Näntö-Salonen et al. 1999; Valtonen et al. 1999).”
BackgroundKreider, R. B., Melton, C., Rasmussen, C. J., Greenwood, M., Lancaster, S., Cantler, E. C., Milnor, P., & Almada, A. L. (2003) · Molecular and Cellular Biochemistry · doi:10.1023/a:1022469320296 · Cited by 181
“There is also recent evidence that creatine supplementation may provide therapeutic benefit for patients with a variety of metabolic disorders [11–15], neuromuscular diseases [16–21], as well hasten recovery following immobilization [22].”
Background
Metadata
- Authors
- Valtonen, M., Näntö‐Salonen, K., Jääskeläinen, S., Heinänen, K., Alanen, A., Heinonen, O. J., Lundbom, N., Erkintalo, M., & Simell, O.
- Affiliations
- University of Turku (FI)
- Sports and Exercise Medicine Unit, Department of Physiology University of Turku Turku Finland
- Venue
- Journal of Inherited Metabolic Disease
- Publisher
- Wiley
- Published
- 1999-12
- Volume
- 22
- Issue
- 8
- Pages
- 855-866
- ISSN
- 0141-8955 (ISSN-L)
- 1573-2665
- OpenAlex
- W215452445
- Cited by
- 46
- References
- 46
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 2 · 2023: 2 · 2022: 2 · 2021: 7 · 2020: 2 · 2017: 2 · 2016: 2 · 2015: 1 · 2014: 2 · 2013: 3
- FWCI
- 0.71
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Inherited Metabolic Disease (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Signe ja Ane Gyllenbergin Säätiö
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Amino Acid Enzymes and Metabolism
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Genetic Neurodegenerative Diseases
- Keywords
- gyrate atrophy of the choroid and retina, central nervous system involvement, white matter degeneration, creatine supplementation, creatine metabolism, guanidinoacetate methyltransferase deficiency, EEG abnormalities, brain MRI
- MeSH terms
- Adolescent, Adult, Aged, Brain, Central Nervous System, Child, Child, Preschool, Choroid, Creatine, Electroencephalography, Female, Humans, Magnetic Resonance Imaging, Male, Middle Aged, Ornithine, Ornithine-Oxo-Acid Transaminase, Retina, Gyrate Atrophy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Central nervous system involvement in gyrate atrophy of the choroid and retina with hyperornithinaemia. https://app.cochat.ai/papers/10.1023/a:1005602405349
- The paper
- Valtonen, M., Näntö‐Salonen, K., Jääskeläinen, S., Heinänen, K., Alanen, A., Heinonen, O. J., Lundbom, N., Erkintalo, M., & Simell, O. (1999). Central nervous system involvement in gyrate atrophy of the choroid and retina with hyperornithinaemia. Journal of Inherited Metabolic Disease. https://doi.org/10.1023/a%3A1005602405349
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.